Approval · Notice of Compliance 21947 · 2019
FLUTAMIDE: Notice of Compliance 21947
Issued March 8, 2019
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 21947
- Date
- March 8, 2019
- Company
- AA Pharma Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Labelling Only
- Reason
- Labelling Assesment and Administrative: Change in Product Ownership
- Canadian reference product
- EUFLEX (Schering Canada Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| FLUTAMIDE | 02238560 | Marketed |
Medicinal ingredients
- FLUTAMIDE 250 MG per TAB